Jci_page_head_homepage_01 Jci_page_head_homepage_02
David Patsouris, Stéphane Mandard, Peter J. Voshol, Pascal Escher, Nguan Soon Tan, Louis M. Havekes, Wolfgang Koenig, Winfried März, Sherrie Tafuri, Walter Wahli, Michael Müller, Sander Kersten
Published in Volume 114, Issue 1
J Clin Invest. 2004; 114(1):94–103 doi:10.1172/JCI20468
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 1

Oligonucleotide microarray analysis identifies novel putative PPARα target genes. (A) Relative expression of PPARα in liver was determined by Q-PCR in fed and 24-hour-fasted mice (n = 4). The difference was evaluated by Student’s t test (P < 0.01). Error bars represent SEM. (B) Expression of genes involved in fatty acid oxidation and ketogenesis in livers of wild-type and PPARα-null mice, as determined by oligonucleotide microarray (Affymetrix). The average difference (expression) of wild-type at 0 hours was arbitrarily set at 100. Filled diamonds: long-chain fatty acyl-CoA synthetase; open diamonds: carnitine palmitoyltransferase II; filled triangles: long-chain acyl-CoA dehydrogenase; open circles: short-chain acyl-CoA dehydrogenase; open triangles: medium-chain acyl-CoA dehydrogenase; filled circles: dodecenoyl-CoA δ-isomerase; filled squares: HMG-CoA synthase; open squares: HMG-CoA lyase. (C) Hepatic expression of PEPCK (left), cGPDH (middle) and mGPDH (right) after 0, 2.5, 5.5 and 24 hours fasting in wild-type and PPARα-null mice according to oligonucleotide microarray. The average difference (expression) of wild-type at 0 hours was arbitrarily set at 100.